Imperial College London


Faculty of MedicineDepartment of Immunology and Inflammation

Chair of the Department of Haematology



+44 (0)20 3313 3237j.apperley




Miss Mandy Sale +44 (0)20 3313 4017




4N3CHammersmith HospitalHammersmith Campus






Innes A, Wooley P, Szydlo R, et al., Complete remission with incomplete count recovery (CRi) prior to allogeneic HCT for acute myeloid leukaemia is associated with a high non-relapse mortality., Leukemia, ISSN:1476-5551

Clark RE, Polydoros F, Apperley JF, et al., 2019, De-escalation of tyrosine kinase inhibitor therapy before complete treatment discontinuation in patients with chronic myeloid leukaemia (DESTINY): a non-randomised, phase 2 trial, Lancet Haematology, Vol:6, ISSN:2352-3026, Pages:e375-e383

Nesr G, Claudiani S, Khorashad J, et al., 2019, The influence of salivary amylase on total amylase elevation in CML patients treated with TKI therapy: a case series of 3 patients, Leukemia & Lymphoma, ISSN:1042-8194

Branford S, Kim DDH, Apperley JF, et al., 2019, Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia., Leukemia, ISSN:0887-6924

Xu D, Claudiani S, Naresh K, et al., 2019, Blast crisis of chronic myeloid leukemia with plasmacytoid dendritic cell phenotype associated with a rare fusion transcript, e13a3 BCR-ABL1., Leuk Lymphoma, Pages:1-2

More Publications